Evotec SE (EVO) Enterprise Value (QoQ) (2009 - 2026)
Evotec SE (EVO) Enterprise Value (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -667.39% |
| Dec 31, 2025 | 75.54% |
| Sep 30, 2025 | 29.59% |
| Jun 30, 2025 | -0.82% |
| Mar 31, 2025 | 99.88% |
| Dec 31, 2024 | 99.87% |
| Mar 31, 2024 | -71,486.03% |
| Dec 31, 2022 | -88,166.26% |
| Sep 30, 2022 | 12.34% |
| Jun 30, 2022 | 1.25% |
| Mar 31, 2022 | 99.88% |
| Dec 31, 2021 | 99.80% |
| Sep 30, 2021 | -2,968,065,455,748.71% |
| Dec 31, 2020 | -650,390,154.71% |
| Sep 30, 2010 | -29,743,263.59% |
| Jun 30, 2010 | 100.00% |
| Mar 31, 2010 | -40,336,074,446.26% |
| Jun 30, 2009 | 4.70% |